123 related articles for article (PubMed ID: 10194163)
1. Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study.
Laatikainen AK; Kröger HP; Tukiainen HO; Honkanen RJ; Saarikoski SV
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1179-85. PubMed ID: 10194163
[TBL] [Abstract][Full Text] [Related]
2. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study.
Kröger H; Honkanen R; Saarikoski S; Alhava E
Ann Rheum Dis; 1994 Jan; 53(1):18-23. PubMed ID: 8311549
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age.
Monadi M; Javadian Y; Cheraghi M; Heidari B; Amiri M
Osteoporos Int; 2015 Jul; 26(7):2013-8. PubMed ID: 25860975
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.
Ebeling PR; Erbas B; Hopper JL; Wark JD; Rubinfeld AR
J Bone Miner Res; 1998 Aug; 13(8):1283-9. PubMed ID: 9718197
[TBL] [Abstract][Full Text] [Related]
5. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.
Chen W; Johnson KM; FitzGerald JM; Sadatsafavi M; Leslie WD
Arch Osteoporos; 2018 Oct; 13(1):116. PubMed ID: 30374631
[TBL] [Abstract][Full Text] [Related]
7. Effect of the long-term use of inhaled corticosteroids on bone mineral density in asthmatic women.
Sivri A; Cöplü L
Respirology; 2001 Jun; 6(2):131-4. PubMed ID: 11422892
[TBL] [Abstract][Full Text] [Related]
8. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
Insua A; Negri A; Zanchetta JR
Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
[TBL] [Abstract][Full Text] [Related]
9. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss.
Nguyen TV; Sambrook PN; Eisman JA
J Bone Miner Res; 1997 Jan; 12(1):124-35. PubMed ID: 9240735
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial.
Campbell IA; Douglas JG; Francis RM; Prescott RJ; Reid DM;
Scott Med J; 2009 Feb; 54(1):21-5. PubMed ID: 19291931
[TBL] [Abstract][Full Text] [Related]
11. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
12. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
Vestergaard P; Hermann AP; Orskov H; Mosekilde L
J Clin Endocrinol Metab; 1999 Jul; 84(7):2286-90. PubMed ID: 10404791
[TBL] [Abstract][Full Text] [Related]
13. Body fat distribution is associated with lumbar spine bone density independently of body weight in postmenopausal women.
Saarelainen J; Honkanen R; Kröger H; Tuppurainen M; Jurvelin JS; Niskanen L
Maturitas; 2011 May; 69(1):86-90. PubMed ID: 21388758
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study.
Luengo M; del Río L; Pons F; Picado C
Eur Respir J; 1997 Sep; 10(9):2110-3. PubMed ID: 9311512
[TBL] [Abstract][Full Text] [Related]
15. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
Diamond T; McGuigan L; Barbagallo S; Bryant C
Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
[TBL] [Abstract][Full Text] [Related]
16. Site of bone density measurement may affect therapy decision.
Lai K; Rencken M; Drinkwater BL; Chesnut CH
Calcif Tissue Int; 1993 Oct; 53(4):225-8. PubMed ID: 8275348
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women.
Kröger H; Tuppurainen M; Honkanen R; Alhava E; Saarikoski S
Calcif Tissue Int; 1994 Jul; 55(1):1-7. PubMed ID: 7922782
[TBL] [Abstract][Full Text] [Related]
18. Increased reduction in bone density and skin thickness in postmenopausal women taking long-term corticosteroid therapy: a suggested role for estrogen add-back therapy.
Baron YM; Brincat MP; Galea R
Climacteric; 1999 Sep; 2(3):189-96. PubMed ID: 11910596
[TBL] [Abstract][Full Text] [Related]
19. Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients.
Herrala J; Puolijoki H; Liippo K; Raitio M; Impivaara O; Tala E; Nieminen MM
Bone; 1998 May; 22(5):577-82. PubMed ID: 9600795
[TBL] [Abstract][Full Text] [Related]
20. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
